These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33333143)

  • 1. Correlationship of Drug-Polymer Miscibility, Molecular Relaxation and Phase Behavior of Dipyridamole Amorphous Solid Dispersions.
    Sharma J; Singh B; Agrawal AK; Bansal AK
    J Pharm Sci; 2021 Apr; 110(4):1470-1479. PubMed ID: 33333143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Drug-Polymer Miscibility on Enthalpy Relaxation of Irbesartan Amorphous Solid Dispersions.
    Dalsania S; Sharma J; Munjal B; Bansal AK
    Pharm Res; 2018 Jan; 35(2):29. PubMed ID: 29368174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the Correlation between Miscibility and Physical Stability of Amorphous Solid Dispersions Using Fluorescence-Based Techniques.
    Tian B; Tang X; Taylor LS
    Mol Pharm; 2016 Nov; 13(11):3988-4000. PubMed ID: 27700109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of Phase Mixing in Amorphous Solid Dispersions of AMG 517 in HPMC-AS Using DSC, Solid-State NMR, and Solution Calorimetry.
    Calahan JL; Azali SC; Munson EJ; Nagapudi K
    Mol Pharm; 2015 Nov; 12(11):4115-23. PubMed ID: 26457879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isothermal microcalorimetry to investigate the phase separation for amorphous solid dispersions of AMG 517 with HPMC-AS.
    Calahan JL; Zanon RL; Alvarez-Nunez F; Munson EJ
    Mol Pharm; 2013 May; 10(5):1949-57. PubMed ID: 23574401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Miscibility of Itraconazole-Hydroxypropyl Methylcellulose Blends: Insights with High Resolution Analytical Methodologies.
    Purohit HS; Taylor LS
    Mol Pharm; 2015 Dec; 12(12):4542-53. PubMed ID: 26567698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring Polymorphic Phase Transitions in Flufenamic Acid Amorphous Solid Dispersions Using Hyphenated X-ray Diffraction-Differential Scanning Calorimetry.
    Pang Y; Buanz A; Gaisford S; Magdysyuk OV; Williams GR
    Mol Pharm; 2022 May; 19(5):1477-1487. PubMed ID: 35347993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
    Purohit HS; Taylor LS
    Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions.
    Meng F; Trivino A; Prasad D; Chauhan H
    Eur J Pharm Sci; 2015 Apr; 71():12-24. PubMed ID: 25686597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into Nano- and Micron-Scale Phase Separation in Amorphous Solid Dispersions Using Fluorescence-Based Techniques in Combination with Solid State Nuclear Magnetic Resonance Spectroscopy.
    Purohit HS; Ormes JD; Saboo S; Su Y; Lamm MS; Mann AKP; Taylor LS
    Pharm Res; 2017 Jul; 34(7):1364-1377. PubMed ID: 28455777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementarity of mDSC, DMA, and DRS Techniques in the Study of
    Thayumanasundaram S; Venkatesan TR; Ousset A; Van Hollebeke K; Aerts L; Wübbenhorst M; Van den Mooter G
    Mol Pharm; 2022 Jul; 19(7):2299-2315. PubMed ID: 35674392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase Behavior of Amorphous Solid Dispersions of Felodipine: Homogeneity and Drug-Polymer Interactions.
    Sarpal K; Delaney S; Zhang GGZ; Munson EJ
    Mol Pharm; 2019 Dec; 16(12):4836-4851. PubMed ID: 31682129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.
    Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Pharm Res; 2016 Oct; 33(10):2445-58. PubMed ID: 27283830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating crystallization tendency, miscibility, and molecular interactions of drug-polymer systems for the development of amorphous solid dispersions.
    Meng F; Paul SK; Borde S; Chauhan H
    Drug Dev Ind Pharm; 2021 Apr; 47(4):579-608. PubMed ID: 33651659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
    McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
    Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a small-scale spray-drying approach for amorphous solid dispersions (ASDs) screening in early drug development.
    Ousset A; Bassand C; Chavez PF; Meeus J; Robin F; Schubert MA; Somville P; Dodou K
    Pharm Dev Technol; 2019 Jun; 24(5):560-574. PubMed ID: 30303440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
    Sarpal K; Tower CW; Munson EJ
    Mol Pharm; 2020 Mar; 17(3):787-801. PubMed ID: 31860316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Miscibility of nifedipine and hydrophilic polymers as measured by (1)H-NMR spin-lattice relaxation.
    Aso Y; Yoshioka S; Miyazaki T; Kawanishi T; Tanaka K; Kitamura S; Takakura A; Hayashi T; Muranushi N
    Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1227-31. PubMed ID: 17666850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of fully amorphous dispersions of a low T(g) drug via co-spray drying with hydrophilic polymers.
    Zhao M; Barker SA; Belton PS; McGregor C; Craig DQ
    Eur J Pharm Biopharm; 2012 Nov; 82(3):572-9. PubMed ID: 22922419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
    Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S
    Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.